Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NPI-001 in Retinitis Pigmentosa Associated With Usher Syndrome
NCT04355689Phase 2Completed
- Sponsor
- Nacuity Pharmaceuticals
- Start
- Sep 2020
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of N-acetylcysteine amide in Usher syndrome, sponsored by Nacuity Pharmaceuticals. Started Sep 2020; status: completed.
02
Drugs
N-acetylcysteine amide
03
Conditions
Usher syndrome
Beyond the preview
Go deeper on NCT04355689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04355689.